(Reuters) – Italy has held talks with several manufacturers about starting production of mRNA-based COVID-19 vaccines in the country, the Financial Times reported https://www.ft.com/content/d4a9e726-4112-461b-a383-5ad9df062712.
Rome has discussed the domestic production of mRNA-based vaccines with Moderna Inc, Switzerland’s Novartis AG and Italy’s ReiThera, the report added, citing people familiar with the matter.
(Reporting by Aakriti Bhalla in Bengaluru; Editing by Christopher Cushing)
Browns QB Deshaun Watson throwing full speed after shoulder surgery, timetable for return unknown
Rory McIlroy debunks LIV Golf rumors. Greg Norman claims unanimous support during Masters trip
Philadelphia 76ers set to start another playoff run with an ailing Joel Embiid
Phoenix Suns and Grayson Allen finalize contract extension after career-best season
BYU hires Suns assistant Kevin Young to replace Mark Pope, who left to coach Kentucky
Man wanted for murder turns himself in following City Avenue killing
Israel says it will retaliate against Iran, despite the risks
West Virginia transgender sports ban discriminates against teen athlete, appeals court says
Facing a Republican revolt, House Speaker Johnson pushes ahead on US aid for Ukraine, allies
Whitey Herzog, Hall of Fame manager who led St. Louis Cardinals to 3 pennants, dies at 92
Biden administration announces new partnership with 50 countries to stifle future pandemics
Weedkiller manufacturer seeks lawmakers’ help to squelch claims it failed to warn about cancer
Indiana limits abortion data for privacy under near-total ban, but some GOP candidates push back
New rules for Pregnant Workers Fairness Act include divisive accommodations for abortion
